Opioid Drugs Market , by Drug Type (Codeine, Fentanyl, Morphine, Hydrocodone, Oxycodone, and Others), by Application (Analgesia, Cough Suppression, and Diarrhea Suppression), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribut
Description
Opioids are a class of drugs which are largely used for relieving pain. One of the first opioid drugs ‘morphine’ was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous system thus providing relief from pain. Opioid are administered in the form of as oral pills, parenteral, liquids, patches or lozenges. There are different types of prescription opioids available such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone which are prescribed by physicians for treating pain.
Market Dynamics
Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure–activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.
Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grünenthal acquired the U.S.-based pharmaceutical company ‘Averitas Pharma’ in order to expand its presence in the U.S.
Key features of the study:
Market Dynamics
Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure–activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.
Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grünenthal acquired the U.S.-based pharmaceutical company ‘Averitas Pharma’ in order to expand its presence in the U.S.
Key features of the study:
- This report provides an in-depth analysis of global opioids market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global opioids market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global opioids market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global opioids market
- Global Opioids Market, By Drug Type:
- Codeine
- Fentanyl
- Morphine
- Hydrocodone
- Oxycodone
- Others
- Global Opioids Market, By Application:
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- Global Opioids Market, By Route of Administration:
- Oral
- Topical
- Parenteral
- Others
- Global Opioids Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Opioids Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma L.P.
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals L.P.
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals (USA) LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited
Table of Contents
203 Pages
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- Reimbursement Scenario
- PEST Analysis
- PORTER’S Analysis
- 4. Global Opioid Drugs Market-COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Opioid Drugs Market, By Drug Class, 2020- 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Alkaloids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- Morphine
- codeine
- Semisynthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- Oxycodone
- Hydrocodone
- Hydromorphone
- Synthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- Fentanyl
- Alfentanil
- 6. Global Opioid Drugs Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Analgesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- Diarrhea Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- 7. Global Opioid Drugs Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- Others (Intramuscular, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Segment Trends
- 8. Global Opioid Drugs Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- 9. Global Opioid Drugs Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
- 10. Competitive Landscape
- Company Profiles
- Teva Pharmaceutical Industries Ltd.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Johnson & Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma L.P.
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals L.P.
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals (USA) LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited
- 11. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 45 market data tables and 35 figures on “Global Opioid Drugs Market”- Global forecast to 2032
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
